Press Releases

  • Low-fat or low-carb? It’s a draw

    Stanford researchers have found that, contrary to previous studies, insulin levels and a specific genotype pattern don’t predict weight-loss success.

  • Seizure-regulating nerve cells identified

    Stanford researchers have found that a small set of nerve cells in the brain regulates the debilitating seizures and cognitive deficits characteristic of the most common form of epilepsy in adults. This discovery could lead to new and better treatments.

  • IPS cells slow tumor growth in mice

    Priming the immune system with induced pluripotent stem cells prevented or slowed the development of cancer in mice, Stanford researchers found.

  • A patient’s bucket list helps physicians

    A Stanford study has has found that a majority of people make bucket lists and suggests they can be useful in doctor-patient discussions about care plans.

  • Potential skin cancer treatment

    Stanford researchers have learned how basal cell carcinoma evades drug treatment without mutating. The researchers found possible drug targets that may allow for more personalized treatment of this common skin cancer.

  • 'Vaccine’ destroys tumors in mice

    Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial.

  • Broader use of acute-stroke therapy pays off

    In a multicenter study led by Stanford researchers, the number of stroke patients who died or required confinement to nursing homes was nearly cut in half, the biggest improvement seen in any stroke-related trial to date.

  • Good math attitude boosts memory power

    A positive attitude toward math boosts the brain’s memory center and predicts math performance independent of factors such as a child’s IQ, a Stanford study has found.

  • Weight flux alters molecular profile

    Stanford scientists have found links between changes in a person’s weight and shifts in their microbiome, immune system and cardiovascular system.

  • Juergen Willmann dies at 45

    Juergen Willmann, an international scholar, dedicated himself to advancing cancer detection imaging technologies and leading with energy and compassion.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.